The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma

References

Page 1

	Year	Citations
CpG Islands in vertebrate genomes Margaret Gardiner‐Garden, Marianne Frommer Journal of Molecular Biology BiologyPhylogeneticsMolecular EcologyNatural SciencesGenetics	1987	3.4K
A Protein Interaction Map of <i>Drosophila melanogaster</i> Loïc Giot, Joel S. Bader, Cory Brouwer, Science GeneticsMolecular GeneticsProtein GeneticsDrosophila MelanogasterProtein Interaction Map	2003	2.3K
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia Stephen B. Baylln, James G. Herman, Jeremy R. Graff, Advances in cancer research ChromatinEpigenetic ChangeGeneticsDna MethylationEpigenomics	1997	1.9K
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 Reinhard Dammann, Chun Li, Jung‐Hoon Yoon, Nature Genetics ChromatinLung Tumour SuppressorMedicineGeneticsEpigenetic Inactivation	2000	1.1K
DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters Keith D. Robertson, Slimane Ait‐Si‐Ali, Tomoki Yokochi, Nature Genetics ChromatinTranscriptional RegulationMedicineGeneticsNatural Sciences	2000	938
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression David G. Burbee, Éva Forgács, Sabine Zöchbauer‐Müller, JNCI Journal of the National Cancer Institute	2001	769
Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Donald Macleod, Jillian Charlton, John J. Mullins, Genes & Development Aprt Island MethylationChromatinTranscriptional RegulationSystems BiologyDevelopmental Biology	1994	590
Low-Dose 5-Aza-2′-Deoxycytidine, a DNA Hypomethylating Agent, for the Treatment of High-Risk Myelodysplastic Syndrome: A Multicenter Phase II Study in Elderly Patients P. Wijermans, Michael Lübbert, G. Verhoef, Journal of Clinical Oncology	2000	570
ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex Jianxiang Wang, Taizo Hoshino, Robert L. Redner, Proceedings of the National Academy of Sciences Mixed-phenotype Acute LeukemiaGeneticsImmunologyAml1/eto FusionEpigenetics	1998	518
Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus Dolly P. Huang, Angela Bik‐Yu Hui, Kwok Wai Lo, International Journal of Cancer	1999	392

Page 1